NEIL3 Mediates Lung Cancer Progression and Modulates PI3K/AKT/mTOR Signaling: A Potential Therapeutic Target

Figure 3

NEIL3 was associated with poor prognostic outcomes in lung cancer patients. Notes: (a–c) association between NEIL3 and patient OS, DSS, and PFI in the TCGA-LUAD cohort; (d–f) association between NEIL3 and patient OS, DSS, and PFI in the TCGA-LUSC cohort; (g, h) univariate and multivariate analyses indicated that NEIL3 was an independent prognostic marker in lung cancer patients.

(a)

(b)

(c)

(d)

(e)

(f)

(g)

(h)